by Madaline Spencer | Jun 30, 2025
Dirk Arnold, MD, PhD, Director of the Asklepios Tumorzentrum Hamburg, discusses the OrigAMI-2 clinical trial in left-sided RAS/BRAF wild-type metastatic colorectal cancer (mCRC). Approximately 50% of patients diagnosed with colorectal cancer have...
by Madaline Spencer | Jun 27, 2025
Peter Voorhees, MD, Atrium Health and Levine Cancer Institute, Wake Forest University School of Medicine, discusses results from the CARTITUDE-1 study in patients with multiple myeloma (MM). MM is a bone marrow-based plasma cell neoplasm characterized by...
by CheckRare Staff | Jun 26, 2025
Neha Mehta-Shah, MD, Medical Oncologist at Washington University St. Louis, provides an overview of cutaneous T-cell lymphoma (CTCL), discusses management options, and addresses quality-of-life concerns. « Prev1 / 1Next »Cutaneous T-Cell Lymphoma:...
by CheckRare Staff | Jun 23, 2025
Jorge Cortes, MD, Director of the Georgia Cancer Center, provides an overview of chronic myeloid leukemia (CML), discusses treatment options, and offers advice to newly diagnosed patients. « Prev1 / 1Next »Chronic Myeloid Leukemia: Overview,...
by Madaline Spencer | Jun 19, 2025
Salomon Manier, MD, PhD, Associate Professor of Hematology at Lille University Hospital in France, discusses results from a phase 1b clinical trial evaluating linvoseltamab combination therapy in patients with relapsed/refractory multiple myeloma (MM). ...
